In vivo and in vitro studies demonstrate that PON-1 protects against the damage caused by hyperhomocysteinemia associated with the development of atherosclerosis and vascular endothelial dysfunction [61], age-related macular degeneration [62], multiple sclerosis [63] and cancer [28]. This evidence concerns the gene PON1 and cancer.